IL6 and hepatocellular carcinoma: To investigate the impact of IL-6 on mortality after trauma plus hemorrhage, SBR35 rats, which also experienced HCC and cardiomyocyte apoptosis (Table 1 and Figure 2), were randomized to receive either placebo or IL-6 (10 μg/kg) at the start of resuscitation (Figure 5).